Made available by
Touch N' Go Systems, Inc., and the
Law Offices of James B. Gottstein.
You can also go to The Alaska Legal Resource Center or search the entire website search.
|
(a) The board will reinstate a pharmaceutical agent prescription and use license endorsement that has been lapsed less than two years if the applicant for reinstatement submits
(1) the required fees established in 12 AAC 02.105 and 12 AAC 02.300; and
(2) documentation that the applicant has met the continuing education requirements in 12 AAC 48.210(d) .
(b) The board will reinstate a pharmaceutical agent prescription and use license endorsement that has been lapsed for two years but less than five years if the applicant for reinstatement submits
(1) the required fees established in 12 AAC 02.105 and 12 AAC 02.300 for the entire period that the endorsement has been lapsed; and
(2) documentation that the applicant
(A) has met the continuing education requirements in 12 AAC 48.210(d) that would have been required to maintain a current endorsement for the entire period that the endorsement has been lapsed; and
(B) completed 12 contact hours of continuing education approved by the board in ocular pathology or pharmacology during the six months immediately before the date that the applicant applied for reinstatement of the endorsement; hours documented under this subparagraph must be taken in addition to those hours documented under (A) of this paragraph.
(c) The board will reinstate a pharmaceutical agent prescription and use license endorsement that has been lapsed for five years or more if the applicant for reinstatement submits
(1) the fees that would have been required to maintain a current license endorsement for the last two full license periods and the current license period; and
(2) documentation that the applicant has
(A) met the continuing education requirements in 12 AAC 48.210(d) that would have been required to maintain a current endorsement for the last two full license periods and the current license period; and
(B) completed 12 contact hours of continuing education approved by the board in ocular pathology or pharmacology during the six months immediately before the date that the applicant applied for reinstatement of the endorsement; hours documented under this subparagraph must be taken in addition to those hours documented under (A) of this paragraph.
(d) If the board accepts an applicant's hours of continuing education to reinstate a pharmaceutical agent prescription and use license endorsement, the applicant may not use the same hours to meet the continuing education requirements for a subsequent renewal of the endorsement.
History: Eff. 10/25/98, Register 148; am 10/14/99, Register 152; am 12/31/2005, Register 176
Authority: AS 08.01.100
Note to HTML Version:
The Alaska Administrative Code was automatically converted to HTML from a plain text format. Every effort has been made to ensure its accuracy, but neither Touch N' Go Systems nor the Law Offices of James B. Gottstein can be held responsible for any possible errors. This version of the Alaska Administrative Code is current through June, 2006.
If it is critical that the precise terms of the Alaska Administrative Code be known, it is recommended that more formal sources be consulted. Recent editions of the Alaska Administrative Journal may be obtained from the Alaska Lieutenant Governor's Office on the world wide web. If any errors are found, please e-mail Touch N' Go systems at E-mail. We hope you find this information useful. Copyright 2006. Touch N' Go Systems, Inc. All Rights Reserved.
Last modified 7/05/2006